A detailed history of Harvest Group Wealth Management, LLC transactions in Horizon Therapeutics Public LTD CO stock. As of the latest transaction made, Harvest Group Wealth Management, LLC holds 30 shares of HZNP stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 30 -0.0%
Holding current value
$0
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

SELL
$62.39 - $113.8 $436 - $796
-7 Reduced 18.92%
30 $3,000
Q3 2022

Nov 08, 2022

SELL
$58.92 - $84.67 $1,944 - $2,794
-33 Reduced 47.14%
37 $2,000
Q2 2022

Aug 04, 2022

BUY
$79.4 - $116.36 $1,111 - $1,629
14 Added 25.0%
70 $6,000
Q1 2022

Apr 21, 2022

BUY
$86.42 - $109.81 $86 - $109
1 Added 1.82%
56 $6,000
Q4 2021

Jan 21, 2022

BUY
$98.56 - $119.91 $5,420 - $6,595
55 New
55 $6,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Harvest Group Wealth Management, LLC Portfolio

Follow Harvest Group Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.